A2A-21056-14923
4 vaccinations
1 coded response
30 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 121 / NY
- Registered
- 2021-01-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-30
Registered in v-safe
-
2021-01-30
Dose 1 — Pfizer-BioNTech
-
2021-01-30
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Chills, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-01
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Swelling, Itching · NoneAdult check-in
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-05
- 2021-02-06
- 2021-02-13
-
2021-02-20
Dose 2 — Pfizer-BioNTech
-
2021-02-20
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-21
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-22
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Joint pains, Muscle or body achesAdult check-in
- 2021-02-23
- 2021-02-25
- 2021-02-26
- 2021-02-27
- 2021-03-07
- 2021-03-13
- 2021-03-20
-
2021-03-27
Survey response — day 35, dose 2MedDRA: Headache, Nasal congestion, Nasopharyngitis — Feeling: Fair · Be unable to work, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Cold symptoms, stuffy nose, headacheMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-27
Report sent to call center — day 35, dose 2Be unable to work · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-04-03
- 2021-05-22
- 2021-08-21
-
2021-11-23
Dose 3 — Pfizer-BioNTech
- 2022-02-20
- 2022-03-09
-
2022-09-17
Dose 4 — Pfizer-BioNTech
- 2022-09-28
- 2022-10-08
- 2022-10-15
- 2022-10-22
- 2022-10-29
- 2022-12-17
- 2023-03-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-30 | Pfizer-BioNTech | |
| 2 | 2021-02-20 | Pfizer-BioNTech | |
| 3 | 2021-11-23 | Pfizer-BioNTech | No |
| 4 | 2022-09-17 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
1 wait over 3 months for a first call
Free text
Release 6 — day 35, dose 2
Symptoms: Cold symptoms, stuffy nose, headache
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Nasal congestion | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release